Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.930
-0.690 (-14.94%)
Nov 18, 2026, 4:00 PM EST - Market closed
Evolent Health Revenue
Evolent Health had revenue of $725.37M in the quarter ending September 30, 2026, with 51.27% growth. This brings the company's total for the last twelve months to $2.34B, up 14.06% year-over-year. In the year 2025, Evolent Health had annual revenue of $1.88B, down -26.56%. That makes Evolent Health the 4,506th largest company in the world by revenue and 1,201st in the United States.
Revenue (ttm)
$2.34B
Revenue Growth
+14.06%
P/S Ratio
0.19
Revenue / Employee
$557,822
Employees
4,200
Market Cap
444.50M
Revenue by Segment
- Medicaid 818.31M 43.6%
- Commercial and Other 593.68M 31.6%
- Medicare 464.24M 24.7%
Fiscal year ended Dec 31, 2025 See the full Evolent Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.88B | -678.51M | -26.56% |
| Dec 31, 2024 | 2.55B | 590.85M | 30.09% |
| Dec 31, 2023 | 1.96B | 611.88M | 45.26% |
| Dec 31, 2022 | 1.35B | 444.06M | 48.91% |
| Dec 31, 2021 | 907.96M | -16.68M | -1.80% |
| Dec 31, 2020 | 924.64M | 237.52M | 34.57% |
| Dec 31, 2019 | 687.12M | 60.06M | 9.58% |
| Dec 31, 2018 | 627.06M | 192.11M | 44.17% |
| Dec 31, 2017 | 434.95M | 180.76M | 71.11% |
| Dec 31, 2016 | 254.19M | 157.31M | 162.38% |
| Dec 31, 2015 | 96.88M | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 25.67M | 17.33M | 207.58% |
| Dec 31, 2012 | 8.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Claritev | 1.02B |
| GoodRx Holdings | 785.23M |
| Phreesia | 507.79M |
| Omada Health | 333.04M |
| HealthStream | 327.95M |
| So-Young International | 240.51M |
| American Well | 211.23M |
| NRC Health | 143.79M |
EVH News
- 8 days ago - Evolent Health management to meet with Oppenheimer - TheFly
- 12 days ago - Evolent Health price target raised to $7 from $6 at Oppenheimer - TheFly
- 13 days ago - Evolent Health Earnings Call Transcript: Q3 2026 - Transcripts
- 13 days ago - Evolent Health Quarterly report: Q3 2026 - Filings
- 13 days ago - Evolent Health Earnings release: Q3 2026 - Filings
- 13 days ago - Evolent Health Slides: Q3 2026 - Filings
- 13 days ago - Evolent Health reports Q3 adjusted EPS 6c, consensus 6c - TheFly
- 13 days ago - Evolent Health backs 2026 revenue view $2.6B-$2.7B, consensus $2.64B - TheFly